Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate/Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma (Protocol No. P06241 Also Known as P202)

NCT01471340 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01471340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01471340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate/Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma (Protocol No. P06241 Also Known as P202)
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
January 9, 2012
Completion date
November 30, 2016
Enrollment
11,744 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma